[1] Kenyon A, Ttibe RM, Nelson Piercy C, et al. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet Med, 2011, 3:25-29.
[2] Li T, Chiang JY. Bile acids as metabolic regulators. Curr Opin Gastroenterol, 2015, 31:159-165.
[3] Hofmann AF, Hagey LR. Bile Acids:Chemistry,Pathochemistry,Biology, Pathobiology, And Therapeutics. Cell Mol Life Sci, 2008, 65:2461-2483.
[4] Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res, 2009, 50: 2340-2357.
[5] Reshetnyak VI. Physiological and molecular biochemical mechanisms of bile formation. World J Gastroenterol, 2013, 19: 7341-7360.
[6] Chiang JY. Bile Acid Metabolism and Signaling.Comprehensive. Physiology, 2013, 3:1191-1212.
[7] Dial EJ, Dawson PA, Lichtenberger LM. In Vitro Evidence that Phosphatidylcholine protects against Indomethacin/Bile Acid-Induced Injury to Cells. Am J Physiol Gastrointest Liver Physiol, 2015, 1308:G217-222.
[8] Martinefski MR, Contin1 MD, Rodriguez MR, et al. Coenzyme Q in pregnant women and rats with intrahepatic cholestasis. Liver Int, 2014, 34:1040-1048.
[9] Castano G, Lucangioli S, Sookoian S, et al. Bile acid pro?les by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci, 2006, 110: 459-465.
[10] Naritaka N, Suzuki M, Sato M, et al. Profile of bile acids in fetal gallbladder and meconium using liquid chromatography-tandem mass spectrometry. Clin Chim Acta, 2015, 446:76-81.
[11] Tribe RM, Dann AT, Kenyon AP, et al. Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy. Am J Gastroenterol, 2010, 105:585-595
[12] Ye L, Liu S, Wang M, et al. High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 860:10-17.
[13] Williamson C, Miragoli M, Sheikh Abdul Kadir S, et al. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy. Dig Dis, 2011, 29:58-61.
[14] Itoh S, Onishi S. Hepatic taurine,glycine and individual bile acids in early human fetus.Early Hum Dev, 2000,57:71-77.
[15] Itoh S, Onishi S, Isobe K, et al. Foetomaternal relationships of serum bile acid pattern estimated by high-pressure liquid chromatography. Biochem J, 1982, 204:141-145.
[16] Geenes V, Lovgren-Sandblom A, Benthin L,et al. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PLoS One, 2014, 9:e83828.
[17] Pascual MJ, Serrano MA, EI-Mir MY, et al. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. Clin Sci (Lond), 2002, 102:587-593.
[18] Chappell LC, Gurung V, Seed PT, et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ, 2012, 344:e3799.
[19] Miragoli M, Kadir SH, Sheppard MN, et al. A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart. Hepatology, 2011, 54:1282-1292.
[20] Bacq Y, Sentilhes L, Reyes HB, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology, 2012, 143:1492-1501.
[21] Lucangioli SE, Castaño G, Contin MD, et al. Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment. Ann Clin Biochem, 2009, 46(Pt 1):44-49. |
